Two Sigma Advisers’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.2M | Sell |
194,900
-772,600
| -80% | -$16.7M | 0.01% | 798 |
|
|
2025
Q1 | $16.1M | Sell |
967,500
-295,700
| -23% | -$4.91M | 0.04% | 392 |
|
|
2024
Q4 | $23.2M | Buy |
1,263,200
+778,900
| +161% | +$14.3M | 0.05% | 278 |
|
|
2024
Q3 | $7.45M | Buy |
484,300
+428,900
| +774% | +$6.6M | 0.02% | 571 |
|
|
2024
Q2 | $900K | Buy |
55,400
+33,400
| +152% | +$543K | ﹤0.01% | 1599 |
|
|
2024
Q1 | $407K | Sell |
22,000
-47,600
| -68% | -$880K | ﹤0.01% | 1952 |
|
|
2023
Q4 | $2.18M | Buy |
69,600
+50,900
| +272% | +$1.59M | 0.01% | 1241 |
|
|
2023
Q3 | $390K | Sell |
18,700
-151,700
| -89% | -$3.16M | ﹤0.01% | 1882 |
|
|
2023
Q2 | $4.08M | Buy |
170,400
+158,100
| +1,285% | +$3.79M | 0.01% | 858 |
|
|
2023
Q1 | $231K | Buy |
+12,300
| New | +$231K | ﹤0.01% | 2226 |
|
|
2022
Q3 | – | Sell |
-16,600
| Closed | -$234K | – | 2522 |
|
|
2022
Q2 | $234K | Sell |
16,600
-40,300
| -71% | -$568K | ﹤0.01% | 2219 |
|
|
2022
Q1 | $1.38M | Buy |
+56,900
| New | +$1.38M | ﹤0.01% | 1462 |
|
|
2021
Q2 | – | Sell |
-189,500
| Closed | -$4.89M | – | 2421 |
|
|
2021
Q1 | $4.89M | Sell |
189,500
-233,100
| -55% | -$6.01M | 0.01% | 861 |
|
|
2020
Q4 | $22.6M | Sell |
422,600
-215,600
| -34% | -$11.5M | 0.06% | 320 |
|
|
2020
Q3 | $26.3M | Buy |
638,200
+238,100
| +60% | +$9.82M | 0.08% | 252 |
|
|
2020
Q2 | $19.4M | Buy |
400,100
+338,400
| +548% | +$16.4M | 0.06% | 334 |
|
|
2020
Q1 | $2.61M | Sell |
61,700
-43,100
| -41% | -$1.82M | 0.01% | 972 |
|
|
2019
Q4 | $4.48M | Sell |
104,800
-2,500
| -2% | -$107K | 0.01% | 885 |
|
|
2019
Q3 | $3.86M | Buy |
107,300
+36,000
| +50% | +$1.3M | 0.01% | 855 |
|
|
2019
Q2 | $1.91M | Sell |
71,300
-1,800
| -2% | -$48.1K | ﹤0.01% | 1230 |
|
|
2019
Q1 | $1.96M | Buy |
73,100
+18,600
| +34% | +$499K | ﹤0.01% | 1238 |
|
|
2018
Q4 | $881K | Buy |
+54,500
| New | +$881K | ﹤0.01% | 1540 |
|